Prograf 0.5 mg Norvégia - norvég - Statens legemiddelverk

prograf 0.5 mg

orifarm as - takrolimus - kapsel, hard - 0.5 mg

Prograf 0.5 mg Norvégia - norvég - Statens legemiddelverk

prograf 0.5 mg

orifarm as - takrolimus - kapsel, hard - 0.5 mg

Prograf 0.5 mg Norvégia - norvég - Statens legemiddelverk

prograf 0.5 mg

orifarm as - takrolimus - kapsel, hard - 0.5 mg

Tacni 1 mg Norvégia - norvég - Statens legemiddelverk

tacni 1 mg

teva sweden ab - takrolimus - kapsel, hard - 1 mg

Tacni 0.5 mg Norvégia - norvég - Statens legemiddelverk

tacni 0.5 mg

teva sweden ab - takrolimus - kapsel, hard - 0.5 mg

Takrozem 0.1 % Norvégia - norvég - Statens legemiddelverk

takrozem 0.1 %

pierre fabre dermatologie - takrolimus - salve - 0.1 %

Promixin 1 mill IE Norvégia - norvég - Statens legemiddelverk

promixin 1 mill ie

orifarm as - kolistimetatnatrium - pulver til inhalasjonsvæske til nebulisator, oppløsning - 1 mill ie

Promixin 1 mill IE Norvégia - norvég - Statens legemiddelverk

promixin 1 mill ie

orifarm as - kolistimetatnatrium - pulver til inhalasjonsvæske til nebulisator, oppløsning - 1 mill ie

Promixin 1 mill IE Norvégia - norvég - Statens legemiddelverk

promixin 1 mill ie

2care4 - kolistimetatnatrium - pulver til inhalasjonsvæske til nebulisator, oppløsning - 1 mill ie

Omvoh Európai Unió - norvég - EMA (European Medicines Agency)

omvoh

eli lilly nederland b.v. - mirikizumab - kolitt, ulcerativ - immunsuppressive - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.